LIPELLA PHARMACEUTICALS INC (LIPO)
US53630L1008 - Common Stock
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research
Lipella Pharmaceuticals Launches Innovative Registry to Advance Oral Lichen Planus Research...
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference
Lipella Pharmaceuticals Unveils Advanced Bladder Imaging Technique at ICICJ Conference...
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q2 2024
Lipella Pharmaceuticals just reported results for the second quarter of 2024.
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Lipella Pharmaceuticals (NASDAQ:LIPO) just reported results for the second quar...
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial
Lipella Pharmaceuticals Doses First Two Patients in Phase 2a Oral Lichen Planus Clinical Trial...
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Pre-market stock movers are a hot topic as we jump into all of the biggest news that has shares heading higher and lower on Tuesday morning!
Why Is LuxUrban Hotels (LUXH) Stock Down 12% Today?
LuxUrban Hotels stock is down on Monday after the company priced a public offering of LUXH shares below its prior closing price.
Why Is vTv Therapeutics (VTVT) Stock Down 46% Today?
VTv Therapeutics stock is falling on Monday as VTVT investors react to the company's cadisegliatin clinical program being put on hold.
Why Is Lipella Pharmaceuticals (LIPO) Stock Up 149% Today?
Lipella Pharmaceuticals stock is up on Monday after the company notified LIPO investors of a Phase 2a clinical trial of LP-310 starting.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth diving into as we check out all of the hottest news affecting shares on Monday morning!
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients
Lipella Pharmaceuticals Initiates Phase 2a Trial for LP-310 in Oral Lichen Planus, Enrolls First Patients...
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 in Oral Lichen Planus...
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q1 2024
Lipella Pharmaceuticals just reported results for the first quarter of 2024.
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q1 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Lipella Pharmaceuticals (NASDAQ:LIPO) just reported results for the first quart...
Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Lipella Pharmaceuticals Announces Abstract Publication at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting...
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q4 2023
Lipella Pharmaceuticals just reported results for the fourth quarter of 2023.
LIPO Stock Earnings: Lipella Pharmaceuticals Reported Results for Q4 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Lipella Pharmaceuticals (NASDAQ:LIPO) just reported results for the fourth quar...
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024
Lipella Pharmaceuticals to Publish Abstract Detailing Compelling Preclinical Support for New Product Candidate at ASCO 2024...
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis
Lipella Pharmaceuticals Announces FDA Type C Meeting for LP-10 for Hemorrhagic Cystitis...
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline
Lipella Pharmaceuticals Announces FDA Clearance of IND for LP-410 for Oral Graft-Versus-Host Disease, Advancing Clinical Pipeline...
Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference
Lipella Pharmaceuticals to Present at PropThink Digital Investor Conference ...
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished...
Lipella's oral GvHD drug candidate gets orphan designation (NASDAQ:LIPO)
Read about Lipella Pharmaceuticals' latest milestone - U.S.
FDA Grants Orphan Designation for Lipella's LP-310 Drug Candidate for Oral Graft-versus-Host Disease
/PRNewswire/ -- Lipella Pharmaceuticals Inc. (Nasdaq: LIPO), a clinical stage pharmaceutical company addressing serious diseases with significant unmet need...